Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Total 13F shares
-
15,660,152
-
Share change
-
+1,113,921
-
Total reported value
-
$87,070,626
-
Price per share
-
$5.56
-
Number of holders
-
51
-
Value change
-
+$6,107,538
-
Number of buys
-
23
-
Number of sells
-
18
Institutional Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q3 2023
As of 30 Sep 2023,
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,660,152 shares.
The largest 10 holders included
Cormorant Asset Management, LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, Polar Capital Holdings Plc, Point72 Asset Management, L.P., BlackRock Inc., VANGUARD GROUP INC, Integral Health Asset Management, LLC, and JPMORGAN CHASE & CO.
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.